PREVALENCE OF CLINICALLY RELEVANT BACTEREMIA AFTER UPPER GASTROINTESTINAL ENDOSCOPY IN BONE-MARROW TRANSPLANT RECIPIENTS

被引:41
作者
BIANCO, JA
PEPE, MS
HIGANO, C
APPELBAUM, FR
MCDONALD, GB
SINGER, JW
机构
[1] FRED HUTCHINSON CANC RES CTR,DIV CLIN RES & PUBL HLTH SCI,SEATTLE,WA 98104
[2] UNIV WASHINGTON,SCH MED,DEPT MED,SEATTLE,WA 98195
关键词
D O I
10.1016/0002-9343(90)90289-P
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
purpose: To determine the prevalence of clinically relevant bacteremia after upper endoscopy in patients undergoing bone marrow transplantation. patients and methods: We retrospectively reviewed the records of 151 patients who received an HLA-identical allogeneic bone marrow transplant (BMT) at the Seattle Veterans Affairs Medical Center between September 1983 and December 1988. Forty-seven patients who required esophago-gastroduodenoscopy (EGD) during their first 100 days after transplant were selected for evaluation. Clinically relevant bacteremia was defined as the development of hypotension, temperature greater than 38.5°C, and a positive blood culture occurring within 24 hours after endoscopy. The presence of acute graft-versus-host disease (GVHD) at the time of endoscopy and the use of prednisone prior to endoscopy were considered possible risk factors for the development of bacteremia. The proportion of subjects who became bacteremic were compared using Fisher's exact test. results: Within 24 hours following endoscopy, nine patients (19%) developed clinically evident bacteremia (hypotension, temperature greater than 38.5°C, and a positive blood culture). Eight of 14 patients receiving prednisone at the time of endoscopy developed bacteremia, compared to one of 33 not receiving prednisone (p <0.01). Nineteen patients had acute GVHD of at least grade 2 at the time of EGD, six of whom developed bacteremia. Although acute GVHD alone did not increase the risk of post-EGD bacteremia in patients not receiving prednisone (one of 21 versus zero of 12, p >0.9), the risk of bacteremia was particularly high in patients with acute GVHD treated with prednisone at the time of EGD (six of seven). conclusion: Allogeneic BMT recipients receiving prednisone for immunoprophylaxis after grafting or for treatment of acute GVHD are at high risk for clinically relevant bacteremia following EGD. Such patients are candidates for antibiotic prophylaxis prior to endoscopy. © 1990.
引用
收藏
页码:134 / 136
页数:3
相关论文
共 13 条
[1]   BACTEREMIA WITH GASTROINTESTINAL ENDOSCOPIC PROCEDURES [J].
BOTOMAN, VA ;
SURAWICZ, CM .
GASTROINTESTINAL ENDOSCOPY, 1986, 32 (05) :342-346
[2]   PROTECTIVE ENVIRONMENT FOR MARROW TRANSPLANT RECIPIENTS - PROSPECTIVE-STUDY [J].
BUCKNER, CD ;
CLIFT, RA ;
SANDERS, JE ;
MEYERS, JD ;
COUNTS, GW ;
FAREWELL, VT ;
THOMAS, ED .
ANNALS OF INTERNAL MEDICINE, 1978, 89 (06) :893-901
[3]  
DIXON WJ, 1983, INTRO STAT ANAL, P278
[4]   CURRENT ISSUES IN PREVENTION OF INFECTIVE ENDOCARDITIS [J].
DURACK, DT .
AMERICAN JOURNAL OF MEDICINE, 1985, 78 (6B) :149-156
[5]  
DURACK DT, 1984, PRINCIPLES PRACTICES, P539
[6]   INFECTIONS IN BONE-MARROW TRANSPLANT RECIPIENTS [J].
ENGELHARD, D ;
MARKS, MI ;
GOOD, RA .
JOURNAL OF PEDIATRICS, 1986, 108 (03) :335-346
[7]   CLINICAL MANIFESTATIONS OF GRAFT VERSUS HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONORS [J].
GLUCKSBERG, H ;
STORB, R ;
FEFER, A ;
BUCKNER, CD ;
NEIMAN, PE ;
CLIFT, RA ;
LERNER, KG ;
THOMAS, ED .
TRANSPLANTATION, 1974, 18 (04) :295-304
[8]  
LUM LG, 1987, BLOOD, V69, P369
[9]   INTESTINAL AND HEPATIC COMPLICATIONS OF HUMAN-BONE MARROW TRANSPLANTATION .1. [J].
MCDONALD, GB ;
SHULMAN, HM ;
SULLIVAN, KM ;
SPENCER, GD .
GASTROENTEROLOGY, 1986, 90 (02) :460-477
[10]   GASTROINTESTINAL INSTRUMENTATION, BACTEREMIA, AND ENDOCARDITIS [J].
SHORVON, PJ ;
EYKYN, SJ ;
COTTON, PB .
GUT, 1983, 24 (11) :1078-1093